(Q40752751)

English

8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway

scientific article published on 4 February 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

author name string

Yin Tintut

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Farhad Parhami

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Anastasia Tsingotjidou

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sotirios Tetradis

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Mary Territo

5

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Linda L Demer

6

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

language of work or name

0 references

publication date

4 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

277

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

14221-14226

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

Glibenclamide relaxes vascular smooth muscle constriction produced by prostaglandin F2 alpha.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

The isoprostanes: unique bioactive products of lipid peroxidation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

Effects of selective prostaglandin EP4 receptor antagonist on osteoclast formation and bone resorption in vitro

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

EP(4) receptors mediate prostaglandin E(2)-stimulated glycosaminoglycan synthesis in human cervical fibroblasts in culture

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

Prostaglandin E(2) increases cyclic AMP and inhibits endothelin-1 production/secretion by guinea-pig tracheal epithelial cells through EP(4) receptors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

Mechanisms of prostaglandin E2-induced interleukin-6 release in astrocytes: possible involvement of EP4-like receptors, p38 mitogen-activated protein kinase and protein kinase C.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

Localization of distinct F2-isoprostanes in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

Increased formation of distinct F2 isoprostanes in hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

Oxidized phospholipids and isoprostanes in atherosclerosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

Role of lipids in osteoporosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

Atherogenic high-fat diet reduces bone mineralization in mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

Interleukin 4, interferon-gamma, and prostaglandin E impact the osteoclastic cell-forming potential of murine bone marrow macrophages.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111551200

21 January 2018

Identifiers

10.1074/JBC.M111551200

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40752751&oldid=1906692988"